6 assets in Gaucher Disease

Therapeutic assets addressing Gaucher Disease, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Velaglucerase Alfa Gaucher Disease	Takeda	P4	A (83)
Eliglustat Gaucher Disease	Peking Union Medical College Hospital	P3	BBB (76)
Alpha Tocopherol Gaucher Disease	Ain Shams University	P3	B (62)
Avr-Rd-02 Gaucher Disease	John Bernat	P1/2	CCC (48)
ly3884961 Gaucher Disease	Prevail Therapeutics	P1/2	CC (47)
Ly-M001 Gaucher Disease	Shanghai Jiao Tong University School of Medicine	Early P1	C (39)